These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Interleukin-2 signaling and the maintenance of self-tolerance. Nelson BH Curr Dir Autoimmun; 2002; 5():92-112. PubMed ID: 11826762 [TBL] [Abstract][Full Text] [Related]
4. Enhanced interaction between SEC2 mutant and TCR Vβ induces MHC II-independent activation of T cells via PKCθ/NF-κB and IL-2R/STAT5 signaling pathways. Fu X; Xu M; Song Y; Li Y; Zhang H; Zhang J; Zhang C J Biol Chem; 2018 Dec; 293(51):19771-19784. PubMed ID: 30352872 [TBL] [Abstract][Full Text] [Related]
5. IL-12 administration reveals diabetogenic T cells in genetically resistant I-Ealpha-transgenic nonobese diabetic mice: resistance to autoimmune diabetes is associated with binding of Ealpha-derived peptides to the I-A(g7) molecule. Trembleau S; Gregori S; Penna G; Gorny I; Adorini L J Immunol; 2001 Oct; 167(7):4104-14. PubMed ID: 11564833 [TBL] [Abstract][Full Text] [Related]
6. CD28 co-stimulation restores T cell responsiveness in NOD mice by overcoming deficiencies in Rac-1/p38 mitogen-activated protein kinase signaling and IL-2 and IL-4 gene transcription. Zhang J; Salojin KV; Delovitch TL Int Immunol; 2001 Mar; 13(3):377-84. PubMed ID: 11222507 [TBL] [Abstract][Full Text] [Related]
7. Peptide-MHC class II dimers as therapeutics to modulate antigen-specific T cell responses in autoimmune diabetes. Masteller EL; Warner MR; Ferlin W; Judkowski V; Wilson D; Glaichenhaus N; Bluestone JA J Immunol; 2003 Nov; 171(10):5587-95. PubMed ID: 14607967 [TBL] [Abstract][Full Text] [Related]
8. Negative signaling contributes to T-cell anergy in trauma patients. Bandyopadhyay G; De A; Laudanski K; Li F; Lentz C; Bankey P; Miller-Graziano C Crit Care Med; 2007 Mar; 35(3):794-801. PubMed ID: 17255857 [TBL] [Abstract][Full Text] [Related]
9. CD4+CD25+ regulatory T cells generated in response to insulin B:9-23 peptide prevent adoptive transfer of diabetes by diabetogenic T cells. Mukherjee R; Chaturvedi P; Qin HY; Singh B J Autoimmun; 2003 Nov; 21(3):221-37. PubMed ID: 14599847 [TBL] [Abstract][Full Text] [Related]
10. Functional consequences of the binding of MHC class II-derived peptides to MHC class II. Feili-Hariri M; Kao H; Mietzner TA; Morel PA Int Immunol; 1996 Dec; 8(12):1857-65. PubMed ID: 8982770 [TBL] [Abstract][Full Text] [Related]
11. Self-peptides that bind with low affinity to the diabetes-associated I-A(g7) molecule readily induce T cell tolerance in non-obese diabetic mice. Ferlin WG; Mougneau E; Hugues S; Appel H; Jang MH; Cazareth J; Beaudoin L; Schricke C; Lehuen A; Wucherpfennig KW; Glaichenhaus N Eur J Immunol; 2004 Oct; 34(10):2656-63. PubMed ID: 15368281 [TBL] [Abstract][Full Text] [Related]
12. A model for antigen-specific T-cell anergy: displacement of CD4-p56(lck) signalosome from the lipid rafts by a soluble, dimeric peptide-MHC class II chimera. Thomas S; Kumar R; Preda-Pais A; Casares S; Brumeanu TD J Immunol; 2003 Jun; 170(12):5981-92. PubMed ID: 12794125 [TBL] [Abstract][Full Text] [Related]
13. Two mechanisms for the non-MHC-linked resistance to spontaneous autoimmunity. Verdaguer J; Amrani A; Anderson B; Schmidt D; Santamaria P J Immunol; 1999 Apr; 162(8):4614-26. PubMed ID: 10202001 [TBL] [Abstract][Full Text] [Related]
14. Inactivation of lck and loss of TCR-mediated signaling upon persistent engagement with complexes of peptide:MHC molecules. Lee JE; Cossoy MB; Chau LA; Singh B; Madrenas J J Immunol; 1997 Jul; 159(1):61-9. PubMed ID: 9200439 [TBL] [Abstract][Full Text] [Related]
15. MHC class II molecules play a role in the selection of autoreactive class I-restricted CD8 T cells that are essential contributors to type 1 diabetes development in nonobese diabetic mice. Serreze DV; Holl TM; Marron MP; Graser RT; Johnson EA; Choisy-Rossi C; Slattery RM; Lieberman SM; DiLorenzo TP J Immunol; 2004 Jan; 172(2):871-9. PubMed ID: 14707058 [TBL] [Abstract][Full Text] [Related]
16. IL-2 signaling prevents T cell anergy by inhibiting the expression of anergy-inducing genes. Duré M; Macian F Mol Immunol; 2009 Feb; 46(5):999-1006. PubMed ID: 18990450 [TBL] [Abstract][Full Text] [Related]
17. Lymphocyte Activation in Health and Disease. Berridge MJ Crit Rev Immunol; 2017; 37(2-6):439-462. PubMed ID: 29773029 [TBL] [Abstract][Full Text] [Related]
18. Partial activation of human T cells by peptide analogs on live APC: induction of clonal anergy associated with protein tyrosine dephosphorylation. Matsushita S; Nishimura Y Hum Immunol; 1997 Mar; 53(1):73-80. PubMed ID: 9127150 [TBL] [Abstract][Full Text] [Related]
19. Differential expression of protein tyrosine kinases and their phosphorylation in murine Th1 cells anergized with class II MHC-peptide complexes. Yu SC; Nag B Immunol Cell Biol; 1997 Jun; 75(3):295-302. PubMed ID: 9243296 [TBL] [Abstract][Full Text] [Related]
20. Molecular role of TGF-beta, secreted from a new type of CD4+ suppressor T cell, NY4.2, in the prevention of autoimmune IDDM in NOD mice. Han HS; Jun HS; Utsugi T; Yoon JW J Autoimmun; 1997 Jun; 10(3):299-307. PubMed ID: 9218758 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]